AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK, July 30, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ: AHCO). Investors who purchased AdaptHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ahco.

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of AdaptHealth Corp. (AHCO) Investigation

NEW YORK, July 30, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) from November 11, 2019 through July 16, 2021 (the "Class Period"). The lawsuit filed in the United States District Court for the Eastern District of Pennsylvania alleges violations of the Exchange Act of 1934.

AHCO INVESTOR ALERT: Bernstein Liebhard Announces that a Securities Class Action Lawsuit Has Been Filed Against AdaptHealth Corp.

RADNOR, Pa., July 22, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of AdaptHealth Corp. ("AdaptHealth") (NASDAQ: AHCO).

Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of AdaptHealth Corp. (NASDAQ: AHCO) Investors

Atlanta, Georgia--(Newsfile Corp. - July 19, 2021) - Holzer & Holzer, LLC is investigating whether AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) complied with federal securities laws. On July 19, 2021, Jehoshaphat Research published a Short Report on AdaptHealth stating that Jehoshaphat Research believes AdaptHealth "is deceiving the investor community via its financial reporting practices." The price of AdaptHealth stock fell following the publication of the report.If you purchased AdaptHealth stock and suffered...

SHAREHOLDER ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it will release its financial results for the second quarter ended June 30, 2021 before the opening of the financial markets on Thursday, August 5, 2021. Management will host a conference call that morning at 8:30 am ET

AdaptHealth Corp. Schedules Second Quarter 2021 Financial Results and Conference Call

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) announced today that its Board of Directors (the “Board”) has appointed Stephen Griggs as Chief Executive Officer of the Company, effective immediately. Mr. Griggs, who is also a member of the Board, joined AdaptHealth in February 2021 as Co-CEO following the Company's acquisition of AeroCare Holdings, Inc., which Mr. Griggs founded and led as President and CEO. The Company also announced t

AdaptHealth Appoints Stephen Griggs Chief Executive Officer

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Steve Griggs, Co-Chief Executive Officer, Josh Parnes, President, and Jason Clemens, CFA, Chief Financial Officer, will meet virtually with investors and present at the following investor conferences: Bank of America 20

AdaptHealth Corp. Announces Participation at Upcoming Investor Conferences

AdaptHealth Corp. (AHCO) CEO Steve Griggs on Q1 2021 Results - Earnings Call Transcript

CrowdStrike

CuriosityStream

Fastly

Palantir Technologies

Shopify

Snowflake

Tesla

Growth stocks continue to sell off as prominent names have dropped 20-30% over the last couple of days.

Growth Sell-Off: Which Stocks I'm Buying Now

That's what can happen when you post big earnings misses.

Why AdaptHealth Dived by Nearly 12% Today

Betterware de Mexico

DraftKings

Open Lending Corp

Opendoor

Repay Holdings Corp

Skillz

SPACs are no longer all the rage in 2021. However, there are still many robust SPACs to buy for long-term portfolios The post 7 of the Most Successful SPACs of the Past Year appeared first on InvestorPlace.

7 of the Most Successful SPACs of the Past Year

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -29.17% and -0.57%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Lags Q1 Earnings and Revenue Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2021. Highlights As previously announced, the Company completed the acquisition of AeroCare Holdings Inc. on February 1, 2021. Integration efforts are on track and the

AdaptHealth Corp. Announces First Quarter 2021 Financial Results

AdaptHealth (AHCO) has been struggling lately, but the selling pressure may be coming to an end soon

AdaptHealth (AHCO) Sees Hammer Chart Pattern: Time to Buy?

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and related services in the United States announced today that it has amended its senior secured credit facilities to increase its term loan by $100 million and to expand the maximum borrowing capacity under its revolvi

AdaptHealth Corp. Announces $300 Million Expansion of Its Credit Facilities to Fund Anticipated M&A Activity

New York, New York--(Newsfile Corp. - April 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of AdaptHealth Corporation ("AdaptHealth" or the "Company") (NASDAQ: AHCO). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether AdaptHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors AdaptHealth Corporation - AHCO

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and related services in the United States, announced today that it will release its financial results for the first quarter ended March 31, 2021 before the opening of the financial markets on Thursday, May 6, 2021. Mana

AdaptHealth Corp. Schedules First Quarter 2021 Financial Results and Conference Call

NEW YORK--(BUSINESS WIRE)-- #AdaptHealth--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AdaptHealth, Inc. (NASDAQ: AHCO) on behalf of AdaptHealth stockholders. Our investigation concerns whether AdaptHealth has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On April 13, 2021, AdaptHealth issued a press release stating that the Company “has learne

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Is Investigating AdaptHealth Corporation on Behalf AdaptHealth Stockholders and Encourages Investors to Contact the Firm

MILWAUKEE, April 14, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against AdaptHealth (NASDAQ: AHCO). The investigation results from inaccurate statements AdaptHealth may have made regarding its business operations and prospects.

Ademi LLP Investigates Claims of Securities Fraud against AdaptHealth Corporation

NEW YORK, April 13, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) resulting from allegations that AdaptHealth might have issued misleading information to the investing public. If you purchased AdaptHealth securities, and/or would like to discuss your legal rights and options please visit AdaptHealth Shareholder Investigation or contact Matthew E.

AHCO INVESTIGATION ALERT: Bernstein Liebhard is Investigating AdaptHealth Corp. For Violations of the Securities Laws

Shares of AdaptHealth Corp. plunged 16.7% in morning trading Tuesday, after the maker of home health care equipment said it has learned that co-Chief Executive Luke McGee has been formally charged in Denmark for tax fraud for past private activity. The stock was on track to suffer the biggest one-day drop since the record plunge of 21.2% on March 18, 2020.

AdaptHealth stock plunges after CEO charged with tax fraud in Denmark

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--The Board of Directors of AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) today issued the following statement: AdaptHealth Corp. has learned that authorities in Denmark have formally charged Co-Chief Executive Officer Luke McGee with alleged tax fraud arising from certain past private activity. The alleged personal conduct occurred between March 2014 and August 2015 and had no connection to AdaptHealth's business. AdaptHealth has placed

AdaptHealth Corp.'s Board of Directors' Statement on Co-Chief Executive Officer Luke McGee

BellRing Brands Inc

Chart Industries

Lovesac Company

NeoGenomics

Q2 Hld

Rackspace Technology, Inc.

Small-cap growth stocks can be thick on potential, but thin in news updates and analysis. Here, we look at seven high-potential small caps, and what the pros have to say about them.

7 Super Small-Cap Growth Stocks to Buy

QuantumScape

Defiance Next Gen SPAC Derived ETF

Virgin Galactic

Hundreds of SPACs have gone public in the past year. That said, here are seven of the best SPACs that deserve your attention right now.

7 SPACs From 2020 Still Holding Strong

AdaptHealth: Why This Fast Grower Is A Buy

News for AdaptHealth Corp Stock (AHCO)